SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 1-May 5, 2011, in…
Author: OphthalmologyWeb
SARcode Corporation To Present Phase 2 Clinical Data For Dry Eye Candidate At The ARVO2011 Annual Meeting
SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 1-May 5, 2011, in…
Progress Seen In Creating Eye Cells From Stem Cells
To push the theoretical promise of stem cell research into the world of viable treatments, scientists have successfully fashioned adult stem cells into the kind of eye cells that fall victim to the onset of age-related macular degeneration, or AMD.
DSAEK Grafts Yield Greater Thickness, Haze Than PK
Patients who underwent Descemet’s stripping automated endothelial keratoplasty had increased corneal thickness and significantly more haze during follow-up than those who underwent penetrating keratoplasty, a study showed.
Progress Seen In Creating Eye Cells From Stem Cells
To push the theoretical promise of stem cell research into the world of viable treatments, scientists have successfully fashioned adult stem cells into the kind of eye cells that fall victim to the onset of age-related macular degeneration, or AMD.
Omeros’ Ophthalmology Product OMS302 Achieves Co-Primary Endpoints In Phase 2b Clinical Study
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b clinical trial…
Omeros’ Ophthalmology Product OMS302 Achieves Co-Primary Endpoints In Phase 2b Clinical Study
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b clinical trial…
Omeros’ Ophthalmology Product OMS302 Achieves Co-Primary Endpoints In Phase 2b Clinical Study
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b clinical trial…
LensART Laser System Receives FDA Clearance For Lens Fragmentation And Anterior Capsulotomy In Cataract Surgery
LensAR, Inc., the leading developer of next-generation laser technology for refractive cataract surgery, announced today that the company has received 510(k) clearance from the FDA for use of the LensART Laser System for anterior capsulotomy and lens f…
Further Studies Needed To Assess Safety, Efficacy Of Superselective Ophthalmic Artery Chemotherapy
Superselective ophthalmic artery chemotherapy should be restricted to more advanced cases of retinoblastoma and should only be given in one eye, a study found.
Omeros’ Ophthalmology Product OMS302 Achieves Co-Primary Endpoints In Phase 2b Clinical Study
Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b…
Omeros’ Ophthalmology Product OMS302 Achieves Co-Primary Endpoints In Phase 2b Clinical Study
Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b…
Treatment of Ocular Allergies
Featured Article
Further Studies Needed To Assess Safety, Efficacy Of Superselective Ophthalmic Artery Chemotherapy
Superselective ophthalmic artery chemotherapy should be restricted to more advanced cases of retinoblastoma and should only be given in one eye, a study found.
Omeros’ Ophthalmology Product OMS302 Achieves Co-Primary Endpoints In Phase 2b Clinical Study
Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b…
LensART Laser System Receives FDA Clearance For Lens Fragmentation And Anterior Capsulotomy In Cataract Surgery
LensAR, Inc., the leading developer of next-generation laser technology for refractive cataract surgery, announced today that the company has received 510(k) clearance from the FDA for use of the LensART Laser System for anterior capsulotomy and lens f…
ISTA Pharmaceuticals Highlights BEPREVE(R) Clinical Data At The 2011 American Academy Of Allergy, Asthma And Immunology (AAAAI) Annual Meeting
ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today announced additional results from the Company’s BEPREVE(R) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies in allergic conjunctivitis. These results were presented in poster sess…
Diabetes Alert Day Raises Awareness Of ‘Silent Killer’ Diabetic Retinopathy
Diabetes is often called the “silent killer” because people who have it are often unaware they are affected. According to the American Diabetes Association, diabetes affects 26 million people – including children – in the United States. Approximately o…
Diabetes Alert Day Raises Awareness Of ‘Silent Killer’ Diabetic Retinopathy
Diabetes is often called the “silent killer” because people who have it are often unaware they are affected. According to the American Diabetes Association, diabetes affects 26 million people – including children – in the United States. Approximately o…
Diabetic Retinopathy Is The Leading Cause Of Blindness Among Working-Age Americans
Diabetes is often called the “silent killer” because people who have it are often unaware they are affected. According to the American Diabetes Association, diabetes affects 26 million people – including children – in the United States. Approximately o…